Disulfiram and cancer immunotherapy: Advanced nano-delivery systems and potential therapeutic strategies

• Autores principales: Di Huang (Autor), Yinsha Yao (Autor), Yifei Lou (Autor), Longfa Kou (Autor), Qing Yao (Autor), Ruijie Chen (Autor)
• Formato: Libro
• Publicado: Elsevier, 2024-12-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

The initial focus of the clinical application of disulfiram was its efficacy in treating alcoholism. However, recent research has revealed its potential as an anti-tumor agent and even as an enhancer of cancer immunotherapy. Disulfiram has received safety approval from the FDA, indicating its safety...